Prevention and treatment of Epstein-Barr virus-associated lymphoproliferative disorders in recipients of bone marrow and solid organ transplants

被引:14
|
作者
Meijer, E
Dekker, AW
Weersink, AJL
Rozenberg-Arska, M
Verdonck, LF
机构
[1] Univ Med Ctr Utrecht, Dept Haematol G03 647, NL-3508 GA Utrecht, Netherlands
[2] Eijkman Winkler Inst, Dept Virol, Utrecht, Netherlands
[3] Eijkman Winkler Inst, Dept Microbiol, Utrecht, Netherlands
关键词
bone marrow transplantation; solid organ transplantation; EBV-LPD; EBV-DNA; prevention; treatment;
D O I
10.1046/j.1365-2141.2002.03887.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:596 / 607
页数:12
相关论文
共 50 条
  • [21] Lymphoproliferative syndromes associated to the Epstein Barr virus in organ transplants
    Hidalgo, M
    Lumbreras, C
    Aguado, JM
    MEDICINA CLINICA, 1996, 107 (08): : 310 - 316
  • [22] Primary bone marrow Epstein-Barr virus-associated polymorphic B-cell lymphoproliferative disorder
    Wang, Wei
    Mai, Brenda
    Ali, Haval
    Savariya, Badal U.
    Chen, Lei
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2022, 44 (05) : E224 - E226
  • [23] INFUSIONS OF DONOR LEUKOCYTES TO TREAT EPSTEIN-BARR VIRUS-ASSOCIATED LYMPHOPROLIFERATIVE DISORDERS AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION
    PAPADOPOULOS, EB
    LADANYI, M
    EMANUEL, D
    MACKINNON, S
    BOULAD, F
    CARABASI, MH
    CASTROMALASPINA, H
    CHILDS, BH
    GILLIO, AP
    SMALL, TN
    YOUNG, JW
    KERNAN, NA
    OREILLY, RJ
    NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (17): : 1185 - 1191
  • [24] Epstein-Barr virus vectors for the treatment of Epstein-Barr virus-associated cancers
    Paillard, F
    HUMAN GENE THERAPY, 1998, 9 (08) : 1119 - 1120
  • [25] Rituximab for the treatment of Epstein-Barr virus associated lymphoproliferative disorders.
    George, D
    Small, TN
    Boulad, F
    Castro-Malaspina, H
    Childs, BH
    Jakubowski, A
    Kernan, NA
    Papadopoulos, EB
    Prasad, V
    Young, JW
    Barnett, L
    O'Reilly, RJ
    BLOOD, 2000, 96 (11) : 405A - 405A
  • [26] FATAL EPSTEIN-BARR VIRUS-ASSOCIATED LYMPHOPROLIFERATIVE DISORDER IN CHILDHOOD
    YATABE, Y
    MORI, N
    OKA, K
    IIJIMA, T
    SAGA, S
    TAKADA, K
    ASAI, J
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 1995, 119 (05) : 409 - 417
  • [27] Unrelated bone marrow transplantation for Epstein-Barr virus-associated T/NK-cell lymphoproliferative disease
    Okamura, T
    Kishimoto, T
    Inoue, M
    Honda, M
    Yamashita, N
    Wakiguchi, H
    Yagita, M
    Hosoi, G
    Sako, M
    Yasui, M
    Yagi, K
    Kawa, K
    BONE MARROW TRANSPLANTATION, 2003, 31 (02) : 105 - 111
  • [28] Are natural killer cells the key to treating Epstein-Barr virus-associated lymphoproliferative disorders?
    Robertson, MJ
    JOURNAL OF CLINICAL INVESTIGATION, 2001, 108 (06): : 801 - 802
  • [29] Epstein-Barr virus-associated lymphoproliferative disorder after autologous bone marrow transplantation: report of two cases
    Hauke, RJ
    Greiner, TC
    Smir, BN
    Vose, JM
    Tarantolo, SR
    Bashir, RM
    Bierman, PJ
    BONE MARROW TRANSPLANTATION, 1998, 21 (12) : 1271 - 1274
  • [30] EPSTEIN-BARR VIRUS AND LYMPHOPROLIFERATIVE DISORDERS
    SULLIVAN, JL
    SEMINARS IN HEMATOLOGY, 1988, 25 (03) : 269 - 279